BACKGROUND & AIMS: Gastrointestinal (GI) motility is regulated by serotonin (5-hydroxytryptamine [5-HT]), which is primarily produced by enterochromaffin (EC) cells in the GI tract. However, the precise roles of EC cell-derived 5-HT in regulating gastric motility remain a major point of conjecture. Using a novel transgenic mouse line, we investigated the distribution of EC cells and the pathophysiologic roles of 5-HT deficiency in gastric motility in mice and humans. METHODS: We developed an inducible, EC cell-specific Tph1CreERT2/+ mouse, which was used to generate a reporter mouse line, Tph1-tdTom, and an EC cell-depleted line, Tph1-DTA. We examined EC cell distribution, morphology, and subpopulations in reporter mice. GI motility was measured in vivo and ex vivo in EC cell-depleted mice. Additionally, we evaluated 5-HT content in biopsy and plasma specimens from patients with idiopathic gastroparesis (IG). RESULTS: Tph1-tdTom mice showed EC cells that were heterogeneously distributed throughout the GI tract with the greatest abundance in the antrum and proximal colon. Two subpopulations of EC cells were identified in the gut: self-renewal cells located at the base of the crypt and mature cells observed in the villi. Tph1-DTA mice displayed delayed gastric emptying, total GI transit, and colonic transit. These gut motility alterations were reversed by exogenous provision of 5-HT. Patients with IG had a significant reduction of antral EC cell numbers and 5-HT content, which negatively correlated with gastric emptying rate. CONCLUSIONS: The Tph1CreERT2/+ mouse provides a powerful tool to study the functional roles of EC cells in the GI tract. Our findings suggest a new pathophysiologic mechanism of 5-HT deficiency in IG.
BACKGROUND & AIMS: Gastrointestinal (GI) motility is regulated by serotonin (5-hydroxytryptamine [5-HT]), which is primarily produced by enterochromaffin (EC) cells in the GI tract. However, the precise roles of EC cell-derived 5-HT in regulating gastric motility remain a major point of conjecture. Using a novel transgenic mouse line, we investigated the distribution of EC cells and the pathophysiologic roles of 5-HT deficiency in gastric motility in mice and humans. METHODS: We developed an inducible, EC cell-specific Tph1CreERT2/+ mouse, which was used to generate a reporter mouse line, Tph1-tdTom, and an EC cell-depleted line, Tph1-DTA. We examined EC cell distribution, morphology, and subpopulations in reporter mice. GI motility was measured in vivo and ex vivo in EC cell-depleted mice. Additionally, we evaluated 5-HT content in biopsy and plasma specimens from patients with idiopathic gastroparesis (IG). RESULTS: Tph1-tdTom mice showed EC cells that were heterogeneously distributed throughout the GI tract with the greatest abundance in the antrum and proximal colon. Two subpopulations of EC cells were identified in the gut: self-renewal cells located at the base of the crypt and mature cells observed in the villi. Tph1-DTA mice displayed delayed gastric emptying, total GI transit, and colonic transit. These gut motility alterations were reversed by exogenous provision of 5-HT. Patients with IG had a significant reduction of antral EC cell numbers and 5-HT content, which negatively correlated with gastric emptying rate. CONCLUSIONS: The Tph1CreERT2/+ mouse provides a powerful tool to study the functional roles of EC cells in the GI tract. Our findings suggest a new pathophysiologic mechanism of 5-HT deficiency in IG.
Authors: Dante J Heredia; Michael D Gershon; Sang Don Koh; Robert D Corrigan; Takanubu Okamoto; Terence K Smith Journal: J Physiol Date: 2013-10-14 Impact factor: 5.182
Authors: Florencia Carbone; Karen Van den Houte; Egbert Clevers; Christopher N Andrews; Athanassos Papathanasopoulos; Lieselot Holvoet; Lukas Van Oudenhove; Philip Caenepeel; Joris Arts; Tim Vanuytsel; Jan Tack Journal: Am J Gastroenterol Date: 2019-08 Impact factor: 10.864
Authors: Christopher T Creedon; Pieter-Jan Verhulst; Kyoung M Choi; Jessica E Mason; David R Linden; Joseph H Szurszewski; Simon J Gibbons; Gianrico Farrugia Journal: J Vis Exp Date: 2013-03-23 Impact factor: 1.355
Authors: Madhusudan Grover; Gianrico Farrugia; Matthew S Lurken; Cheryl E Bernard; Maria Simonetta Faussone-Pellegrini; Thomas C Smyrk; Henry P Parkman; Thomas L Abell; William J Snape; William L Hasler; Aynur Ünalp-Arida; Linda Nguyen; Kenneth L Koch; Jorges Calles; Linda Lee; James Tonascia; Frank A Hamilton; Pankaj J Pasricha Journal: Gastroenterology Date: 2011-02-04 Impact factor: 22.682
Authors: Anthony J Treichel; Isabelle Finholm; Kaitlyn R Knutson; Constanza Alcaino; Sara T Whiteman; Matthew R Brown; Aleksey Matveyenko; Andrew Wegner; Halil Kacmaz; Arnaldo Mercado-Perez; Gabriella Bedekovicsne Gajdos; Tamas Ordog; Madhusudan Grover; Joseph Szurszewski; David R Linden; Gianrico Farrugia; Arthur Beyder Journal: Gastroenterology Date: 2021-10-22 Impact factor: 22.682
Authors: Se Eun Ha; Brian G Jorgensen; Lai Wei; Byungchang Jin; Min-Seob Kim; Sandra M Poudrier; Rajan Singh; Allison Bartlett; Hannah Zogg; Sei Kim; Gain Baek; Masaaki Kurahashi; Moon-Young Lee; Yong-Sung Kim; Suck-Chei Choi; Kent C Sasse; Samuel J S Rubin; Andres Gottfried-Blackmore; Laren Becker; Aida Habtezion; Kenton M Sanders; Seungil Ro Journal: Int J Mol Sci Date: 2022-04-30 Impact factor: 6.208
Authors: Kelly L Buchanan; Laura E Rupprecht; M Maya Kaelberer; Atharva Sahasrabudhe; Marguerita E Klein; Jorge A Villalobos; Winston W Liu; Annabelle Yang; Justin Gelman; Seongjun Park; Polina Anikeeva; Diego V Bohórquez Journal: Nat Neurosci Date: 2022-01-13 Impact factor: 28.771